Abeona Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Abeona Therapeutics stock have an average target of 17, with a low estimate of 15 and a high estimate of 21. The average target predicts an increase of 280.74% from the current stock price of 4.47.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$15	$17	$16	$21
Change	+235.95%	+280.74%	+258.34%	+370.32%

Analyst Ratings

The average analyst rating for Abeona Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	2	3	3
Buy	1	1	1	1	1	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	4	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $15	Strong Buy	Reiterates	$15	+235.95%	Mar 24, 2025
Francois Brisebois Oppenheimer	Oppenheimer	Buy Initiates $16	Buy	Initiates	$16	+258.34%	Mar 5, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $15	Strong Buy	Reiterates	$15	+235.95%	Feb 19, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $15	Strong Buy	Reiterates	$15	+235.95%	Nov 25, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $15	Strong Buy	Reiterates	$15	+235.95%	Oct 31, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

12.53M

Revenue Next Year

82.93M

from 12.53M

561.86%

from 12.53M

EPS This Year

-0.68

from -1.55

EPS Next Year

-0.13

from -0.68

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	10.00M	3.00M	1.41M	3.50M	-	12.53M	82.93M	173.08M
Revenue Growth	-	-70.00%	-52.87%	147.53%	-	-	561.86%	108.72%
EPS	-22.73	-21.57	-5.53	-2.53	-1.55	-0.68	-0.13	0.69
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	6.50
No. Analysts	-	-	-	-	-	8	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	15.8M	111.8M	230.4M
Avg	12.5M	82.9M	173.1M
Low	8.8M	55.9M	93.1M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	792.6%	177.8%
Avg	-	561.9%	108.7%
Low	-	345.8%	12.3%

EPS Forecast

EPS	2025	2026	2027
High	1.20	-0.08	1.74
Avg	-0.68	-0.13	0.69
Low	-1.14	-0.20	-0.04

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.